Skip to content

Comparison of Clomiphene Citrate and Cetrotide in Fertility Outcomes with Egg Fertilization Method in the Laboratory

Comparison of clomiphene citrate and Cetrotide in IVF (In Vitro Fertilization)cycles to prevent LH surge and pregnancy results.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240806062668N1
Enrollment
68
Registered
2024-08-07
Start date
2024-08-10
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: Intervention group: In the intervention group, clomiphene citrate 150 mg (Aburihan Pharmaceutical Company) will be prescribed to the patient daily from the time of observation of the f

Sponsors

Vice chancellor for Research, Tabriz University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Infertile women aged 40-20 years Antral Follicle Count (AFC) top four on the third day of the menstrual cycle The base FSH less than IU / L15

Exclusion criteria

Exclusion criteria: Endometriosis grade 3 and 4 Any contraindications for ovarian stimulation

Design outcomes

Primary

MeasureTime frame
Number of resulted oocytes. Timepoint: The day of oocytes pick up. Method of measurement: Microscopic evaluation.;Quality of resulted oocytes. Timepoint: The day of oocytes pick up. Method of measurement: Microscopic evaluation.;Chemical pregnancy. Timepoint: 2 weeks after IVF and embryo transfer. Method of measurement: serum ß-HCG level.

Secondary

MeasureTime frame
Implantation. Timepoint: 4 weeks after IVF and embryo transfer. Method of measurement: Transvaginal sonography to detect gestational sacs.;Clinical Pregnancy. Timepoint: 6 weeks after embryo transfer. Method of measurement: Detection of gestational sac and fetal heart rate on transvaginal sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParvin Hakimi

Tabriz University of Medical Sciences

lahroudin@gmail.com+98 35519161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026